N/A N=12 Trial of Aripiprazole in Trichotillomania
Trichotillomania
Primary: Mass General Hair Pulling Scale — -7.8 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=15 Feasibility Study for Treating Trichotillomania With Wearable Device and App System
Trichotillomania
Primary: Percentage of Participants in the HabitAware Condition That Wore the Device for 6 Hours Per Day and More Than 4 Days Per Week. — 9; 0 Participants
Phase 2 N=20 Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania
Trichotillomania
Primary: Mean Change in Massachusetts General Hospital Hairpulling Scale Baseline to Post-treatment — 6.695 Units on a scale — p=<0.05
Phase 2 N=39 N-Acetylcysteine for Pediatric Trichotillomania
Trichotillomania · Hair Pulling
Primary: Massachusetts General Hospital Hair Pulling Scale (MGH-HPS) — 10.70; 13.53 units on a scale
Phase 2 N=38 Inositol in Trichotillomania
Trichotillomania · Hair Pulling
Primary: The National Institute of Mental Health Trichotillomania Symptom Severity Scale (NIMH-TSS) — 8.4; 8.4 units on a scale
Phase 2 N=50 N-Acetyl Cysteine in Trichotillomania
Trichotillomania
Primary: Massachusetts General Hospital Hairpulling Scale — 17.6; 16.7; 10.4; 16.0 units on a scale
Phase 2 N=51 Naltrexone in the Treatment of Trichotillomania
Trichotillomania
Primary: National Institute of Mental Health Trichotillomania Symptom Severity Scale — 7.94; 8.73 units on a scale
Phase 3 N=50 Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors
Trichotillomania · Skin-Picking
Primary: NIMH Trichotillomania Symptom Severity Scale (NIMH-TSS) — 12.38; 10.63 score on a scale
Phase 2 N=22 Milk Thistle in Trichotillomania in Children and Adults
Trichotillomania · Hair Pulling Disorder
Primary: Change in NIMH Trichotillomania Severity Scale (NIMH-TSS) Scores — 9.4; 9.4; 6.3; 7.4 score on a scale
Phase 2 N=14 Marinol in Trichotillomania or Obsessive Compulsive Disorder
Trichotillomania · Obsessive Compulsive Disorder
Primary: Massachusetts General Hospital Hairpulling Scale (MGH-HPS) Total Score — 8.71 units on a scale
N/A N=33 Developing Effective Response Inhibition Training for Symptom Relief in OCD and Trichotillomania
Obsessive Compulsive Disorder · Trichotillomania
Primary: Composite Score of Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and National Institute of Mental Health (NIMH) — -.38; .46; -.89; -.52 z scores — p== 0.56
Phase 2 N=66 N-Acetyl Cysteine in Pathologic Skin Picking
Pathologic Skin Picking · Neurotic Excoriation · Psychogenic Excoriation
Primary: Yale Brown Obsessive Compulsive Scale (YBOCS) Modified for PSP (NE-YBOCS) — 18.8; 17.6; 16.1; 17.3 units on a scale
Phase 2 N=60 Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)
Alopecia Areata
Primary: Change From Baseline in the Severity of Alopecia Tool (SALT) Score at Week 24 — -6.3; 2.3 score on a scale
N/A N=30,901 Healthcare Disparities in Alopecia Areata
Alopecia Areata
Primary: Likelihood of Depressive Episodes — 1217; 3576 Participants
N/A N=1 Transcranial Magnetic Stimulation Treatment of Hoarding Disorder
Hoarding
Primary: The Saving Inventory-Revised (SI-R) Total Score — 66; 60; 46; 45 units on a scale
N/A N=120 Cognitive-Behavioral Therapy and Supportive Psychotherapy for Body Dysmorphic Disorder
Body Dysmorphic Disorder · Obsessive-Compulsive Spectrum Disorder · Anxiety Disorders
Primary: Body Dysmorphic Disorder Symptoms (as Measured by the BDD-YBOCS) — 32.21; 31.49; 26.92; 27.27 score on a scale — p=<.01
Phase 2 N=35 Double-Blind Lamictal (Lamotrigine) in Neurotic Excoriation
Neurotic Excoriation · Pathologic Skin Picking · Psychogenic Excoriation
Primary: The Yale-Brown Obsessive Compulsive Scale Modified for Neurotic Excoriation (NE-YBOCS) Will be the Primary Outcome Measure — 15.25; 16.13 units on a scale
Phase 2 N=12 Treatment of Depersonalization Disorder With Transcranial Magnetic Stimulation (TMS)
Depersonalization Disorder
Primary: Cambridge Depersonalization Scale (CDS) — 6 responders (>50% reduction in CDS score)
N/A N=7 Rapid Non-Invasive Brain Stimulation for OCD (oTMS)
OCD
Primary: Number of Patients Who Met and Exceeded Response Criteria of Yale-Brown Obsessive-Compulsive Scale. — 4 Participants
N/A N=30 Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
Alopecia Areata
Primary: Number of Patients With SALT50 — 1; 1 Participants
N/A N=10 Response Inhibition in Tourette Syndrome
Tourette Syndrome
Primary: Stop Signal Reaction Time (SSRT) — 249; 245 milliseconds — p=0.49
Phase 2 N=11 N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder
Obsessive-Compulsive Disorder
Primary: OCD Severity at 12 Weeks — 21.4; 21.3 points on a scale
Phase 3 N=718 PF-06651600 for the Treatment of Alopecia Areata
Alopecia Areata
Primary: Percentage of Participants With an Absolute Severity of Alopecia Tool (SALT) Score of Less Than or Equal to 20 at Week 24 — 30.65; 22.31; 23.39; 14.29 Percentage of…